Movement Alert｜Medtronic Rises 3.63% in Regular Trading, Earnings Beat and Analyst Upgrade Extend Post-Report Rally

Market Focus06-04 21:56

On June 4, Medtronic rose 3.63% in regular trading, trading at $82.09/share, with trading volume of $175 million. The stock continued its strong momentum following the prior session's earnings-driven surge.

On the news front, Medtronic reported fiscal Q4 revenue of $9.807 billion, exceeding the consensus estimate of $9.635 billion, and achieved its strongest annual revenue growth in a decade. The core Cardiovascular Portfolio delivered 13.8% year-over-year growth, fueled by robust demand for its pulsed field ablation product suite. Additionally, BTIG upgraded Medtronic from Neutral to Buy with a $90 price target, further bolstering market sentiment. The company also announced strategic investments in two intracardiac echocardiography catheter companies to support cardiac ablation portfolio expansion, and filed a 510(K) application to expand its Hugo robotic-assisted surgery system into general surgery and gynecology in the U.S.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150872575?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 21:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150872575","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Medtronic Rises 3.63% in Regular Trading, Earnings Beat and Analyst Upgrade Extend Post-Report Rally","media":"Market Focus","content":"<p><p>On June 4, Medtronic rose 3.63% in regular trading, trading at $82.09/share, with trading volume of $175 million. The stock continued its strong momentum following the prior session's earnings-driven surge.</p><p>On the news front, Medtronic reported fiscal Q4 revenue of $9.807 billion, exceeding the consensus estimate of $9.635 billion, and achieved its strongest annual revenue growth in a decade. The core Cardiovascular Portfolio delivered 13.8% year-over-year growth, fueled by robust demand for its pulsed field ablation product suite. Additionally, BTIG upgraded Medtronic from Neutral to Buy with a $90 price target, further bolstering market sentiment. The company also announced strategic investments in two intracardiac echocardiography catheter companies to support cardiac ablation portfolio expansion, and filed a 510(K) application to expand its Hugo robotic-assisted surgery system into general surgery and gynecology in the U.S.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Medtronic Rises 3.63% in Regular Trading, Earnings Beat and Analyst Upgrade Extend Post-Report Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Medtronic Rises 3.63% in Regular Trading, Earnings Beat and Analyst Upgrade Extend Post-Report Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-04 21:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 4, Medtronic rose 3.63% in regular trading, trading at $82.09/share, with trading volume of $175 million. The stock continued its strong momentum following the prior session's earnings-driven surge.</p><p>On the news front, Medtronic reported fiscal Q4 revenue of $9.807 billion, exceeding the consensus estimate of $9.635 billion, and achieved its strongest annual revenue growth in a decade. The core Cardiovascular Portfolio delivered 13.8% year-over-year growth, fueled by robust demand for its pulsed field ablation product suite. Additionally, BTIG upgraded Medtronic from Neutral to Buy with a $90 price target, further bolstering market sentiment. The company also announced strategic investments in two intracardiac echocardiography catheter companies to support cardiac ablation portfolio expansion, and filed a 510(K) application to expand its Hugo robotic-assisted surgery system into general surgery and gynecology in the U.S.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDT","symbol_name":"美敦力","start_time":0,"source_url":"","article_id":"1150872575","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150872575","pubTimestamp":1780581403,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 4, Medtronic rose 3.63% in regular trading, trading at $82.09/share, with trading volume of $175 million. The stock continued its strong momentum following the prior session's earnings-driven...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDT":"美敦力"},"translate_title":"走势警报|美敦力(Medtronic)常规交易上涨3.63%，盈利超出预期，分析师上调评级延续报告后涨势","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":1},"content_text":"On June 4, Medtronic rose 3.63% in regular trading, trading at $82.09/share, with trading volume of $175 million. The stock continued its strong momentum following the prior session's earnings-driven surge.On the news front, Medtronic reported fiscal Q4 revenue of $9.807 billion, exceeding the consensus estimate of $9.635 billion, and achieved its strongest annual revenue growth in a decade. The core Cardiovascular Portfolio delivered 13.8% year-over-year growth, fueled by robust demand for its pulsed field ablation product suite. Additionally, BTIG upgraded Medtronic from Neutral to Buy with a $90 price target, further bolstering market sentiment. The company also announced strategic investments in two intracardiac echocardiography catheter companies to support cardiac ablation portfolio expansion, and filed a 510(K) application to expand its Hugo robotic-assisted surgery system into general surgery and gynecology in the U.S.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150872575","isCrawlerRequest":true}